Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course

被引：3
|
作者：
Salmerón, J
Vivaldi, RM
De la Mata, M
Romero, M
Moreno, JP
Aguilar, J
Palacios, A
Nogueras, F
Vignote, M
Alcántara, R
Suarez, E
Andrade, R
Rodriguez, L
Sanchez, H
Quintero, D
机构：
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)81037-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [1] Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience
    Brillanti, S
    Miglioli, M
    Barbara, L
    JOURNAL OF HEPATOLOGY, 1995, 23 : 13 - 16
  • [2] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [3] Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant α-interferon
    Bresci, G
    Parisi, G
    Bertoni, M
    Scatena, F
    Capria, A
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (01) : 75 - 78
  • [4] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [5] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [6] Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α
    Tromm, A
    Greving, I
    Hueppe, D
    GASTROENTEROLOGY, 1999, 116 (04) : A834 - A834
  • [7] Combination therapy with interferon alfa and ribavirin in interferon alfa relapsers.
    Ricchiuti, A
    Ciccorossi, P
    Costa, F
    Bellini, M
    Tumino, E
    Petruccelli, S
    Maggi, F
    Vatteroni, L
    Pistello, M
    Bendinelli, M
    Maltinti, G
    Marchi, S
    HEPATOLOGY, 1996, 24 (04) : 1076 - 1076
  • [8] Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
    Pessoa, Mario G.
    Cheinquer, Hugo
    Almeida, Paulo R. L.
    Silva, Giovanni F.
    Lima, Maria Patelli J. S.
    Parana, Raymundo
    Lacerda, Marco A.
    Parise, Edison R.
    Pernambuco, Jose R. B.
    Pedrosa, Suelene S.
    Teixeira, Rosangela
    Sette, Hoel, Jr.
    Tatsch, Fernando
    ANNALS OF HEPATOLOGY, 2012, 11 (01) : 52 - 61
  • [9] A systematic review on interferon-alpha with or without ribavirin for interferon naive, non-responders, and relapsers with chronic hepatitis C
    Kjaergard, LL
    Krogsgaard, K
    Gluud, C
    JOURNAL OF HEPATOLOGY, 2001, 34 : 180 - 180
  • [10] Interferon/ribavirin treatment in interferon non-responders with chronic hepatitis C.
    Teuber, G
    Berg, T
    Leidig, L
    Hoffmann, RM
    Lafrenz, M
    Spengier, U
    Hopf, U
    Zeuzem, S
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
12345